132
Participants
Start Date
March 31, 2009
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Treatment switching
If the patients do not response to first AntiTNF treatment, Investigator can switch to another anti TNF.Spanish Guidelines will be provided to the investigators, which recommend stopping biologics if there is an inadequate response after 16w of therapy and switch to another biologic. Responsive patients to the first anti-TNF who continue with this first anti-TNF adjusting dose treatment according to the Spanish guidelines or investigator criteria. The doses for each Anti TNF will be done following specific SmPc and under Investiagtor criteria
Pfizer Investigational Site, Madrid
Lead Sponsor
Pfizer
INDUSTRY